Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Jinshazhou Hospital is a comprehensive tertiary-level medical institution located in Guangzhou, China, and serves as an affiliated hospital of the Guangzhou University of Chinese Medicine. The hospital is a large-scale healthcare provider that integrates clinical treatment, medical education, and scientific research, with a specialized focus on oncology, orthopedics, and rehabilitation. It is notably recognized for its advanced International Cancer Center, which utilizes cutting-edge radiotherapy technologies such as the Varian Halcyon and TrueBeam systems. By combining Traditional Chinese Medicine with modern Western medical practices, the hospital offers a multidisciplinary approach to complex disease management. As a significant clinical research site, it collaborates with pharmaceutical companies to conduct Phase I through Phase III clinical trials across various therapeutic areas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinshazhou Hospital and Guangzhou University of Chinese Medicine.